Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES
H01A ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES
H01AC Somatropin and somatropin agonists
H01AC07 Somapacitan
D11194 Somapacitan (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
Somapacitan
D11194 Somapacitan (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
24 Hormones
241 Pituitary hormone preparations
2412 Anterior pituitary hormones
D11194 Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN)
Drug groups [BR:br08330]
Hormonal agent
DG03170 Growth hormone receptor agonist
D11194 Somapacitan
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
CSF and other factor receptors
GHR
D11194 Somapacitan (USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11194
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11194
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11194
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11194
